Introduction
============

Diabetic retinopathy (DR) is the leading cause of blindness in the US affecting people between the ages of 20 and 74 years[@b1-opth-9-2175] and is a prominent cause of visual impairment in the developing world.[@b2-opth-9-2175] Increased duration of diabetes, ineffective blood glucose control, and ineffective blood pressure control are the major risk factors for DR.[@b3-opth-9-2175] However, the incidence and progression of DR among patients with similar metabolic factors may vary substantially.[@b4-opth-9-2175] Furthermore, race, ethnicity, and sex appear to correlate with rates of DR. In the US, DR has been reported to be "slightly more prevalent" in men than in women (*P*=0.04),[@b5-opth-9-2175] but this finding has not been replicated on a worldwide scale.[@b6-opth-9-2175] All races and ethnicities are affected by DR, but some populations might be at higher risk. In the US, African--Americans and Hispanics have significantly higher reported rates of DR than non-Hispanic whites;[@b7-opth-9-2175] for example, in one series, non-Hispanic blacks had significantly higher rates than non-Hispanic whites of DR (*P*=0.01) and vision-threatening DR (*P*=0.01).[@b5-opth-9-2175] Reports on multiple populations from multiple nations suggest that African/Afro-Caribbean, South Asian, Latin American, and indigenous tribal populations have relatively higher rates of DR; the differences achieved statistical significance in some but not all of these studies.[@b7-opth-9-2175],[@b8-opth-9-2175] Taken together, these findings suggest a genetic influence on the development and progression of DR. Heritability has been estimated as high as 27% for DR and 52% for proliferative diabetic retinopathy (PDR).[@b9-opth-9-2175]--[@b11-opth-9-2175]

This manuscript attempts to review the present literature regarding associations between various gene variants and DR. PubMed was searched using the terms "((("2012/01/01"\[Date -- Publication\]: "3000"\[Date -- Publication\])) AND (Diabetic AND Retinopathy)) AND Genetics" so that articles published following a previous review article on this subject[@b12-opth-9-2175] would be included. The intent was to create a relatively concise review to give the practicing clinician an appreciation for the current knowledge regarding genetic contributors to DR. This is not an all-inclusive document and it is likely that other genes and polymorphisms that have been studied with respect to DR have been missed by the search strategy.

Most genotype--phenotype studies of DR have used either individual candidate gene analyses or systematic genome-wide association studies.[@b13-opth-9-2175] Many gene variants have been studied for possible associations with DR. These include well-studied genes ([Table 1](#t1-opth-9-2175){ref-type="table"}) that are believed to contribute to the pathogenesis of diabetes or DR, as well as many more recently described and less understood gene variants ([Table 2](#t2-opth-9-2175){ref-type="table"}), as well as genes for which no positive associations have been reported ([Table 3](#t3-opth-9-2175){ref-type="table"}).

Well-studied candidate genes
============================

Four well-studied candidate genes, which encode proteins that are believed to be important in the pathogenesis of diabetes or DR, include vascular endothelial growth factor (*VEGF*), receptor for advanced glycation end products (*RAGE*), endothelial nitric oxide synthase (*eNOS*), and aldose reductase (*AR*).

AR
--

AR converts glucose to sorbitol in the polyol pathway;[@b14-opth-9-2175] sorbitol cannot cross cell membranes but can accumulate in insulin-independent tissues, where it draws in water and produces osmotic stress.[@b15-opth-9-2175] Multiple studies have reported conflicting results regarding a potential association between *AKR1B1* and DR.[@b16-opth-9-2175]--[@b26-opth-9-2175] For example, the C(−106)T polymorphism was significantly associated with DR in a series of 206 Iranian patients with type 2 diabetes (*P*=0.03)[@b27-opth-9-2175] but not in a series of 268 Chinese patients with type 2 diabetes.[@b28-opth-9-2175] A meta-analysis of 7,831 patients from 17 studies from Asia, South America, Europe, and Australia reported a significant association between the C(−106)T polymorphism and DR in patients with type 1 diabetes (odds ratio \[OR\] =1.78, 95% confidence interval \[CI\] =1.39--2.28) but not type 2.[@b29-opth-9-2175]

eNOS
----

eNOS is involved in regulating vascular tone by inhibiting smooth muscle contraction and platelet aggregation.[@b30-opth-9-2175] Two studies (both including patients with type 1 and type 2 diabetes), a meta-analysis including nine studies comprising 3,145 patients from multiple nations,[@b31-opth-9-2175] and one including 1,446 Asian Indian patients,[@b32-opth-9-2175] reported that the 4a allele of a variable number tandem repeat (VNTR) in the gene was negatively associated with DR (*P*=0.005)[@b31-opth-9-2175] and PDR (*P*=0.03).[@b32-opth-9-2175] Another meta-analysis of 16 studies comprising 6,664 patients reported that the AA genotype of 27VNTR (4a/b) was negatively associated with DR in type 2 diabetes (OR =0.75, 95% CI =0.65--0.88), but only in African populations (of note, the analysis included two studies containing a total of 1,447 patients of African ancestry from the US and Tunisia) and not in Caucasian or Asian populations.[@b33-opth-9-2175] A series of 577 Slovenian patients reported that the A allele of 27VNTR (4a/b) was significantly associated with PDR in type 2 diabetes (*P*=0.01).[@b34-opth-9-2175] Other studies, however, reported no significant associations between *eNOS* polymorphisms and DR in type 2 diabetes.[@b35-opth-9-2175]--[@b37-opth-9-2175]

RAGE
----

RAGE regulates oxidative stress and endothelial function in type 2 diabetes.[@b38-opth-9-2175] A series of 577 Malaysian patients reported no associations between the −429 T/C polymorphism or the −374T/A polymorphism and DR in type 2 diabetes.[@b39-opth-9-2175] A meta-analysis of eleven studies containing a subgroup of seven studies including 3,339 Asian, African, and Caucasian patients reported that the AA genotype of the −374T/A polymorphism was negatively associated with DR in type 2 diabetes (OR =0.64, 95% CI =0.42--0.99).[@b40-opth-9-2175] Alternatively, a series of 758 North Indian patients reported a significant association between the homozygous Ser82 genotype of the Gly82Ser polymorphism with DR in type 2 diabetes (*P*\<0.033).[@b41-opth-9-2175] However, one series of 283 Malaysian patients with type 2 diabetes[@b42-opth-9-2175] and one meta-analysis of over 1,000 patients from 29 studies from the US, Europe, and Asia[@b43-opth-9-2175] reported no associations between *RAGE* polymorphisms and DR.

VEGF
----

The best studied gene in the context of DR is *VEGF*. VEGF is involved in the pathogenesis of PDR and diabetic macular edema, and anti-VEGF drugs have become widely used in the treatment of DR. Four well-studied polymorphisms include rs833061 (−460T/C), rs699947 (−2578C/A), rs2010963 \[(405G/C) and (634 G/C)\], and rs3025039 (+936C/T).

### rs833061 (−460T/C)

A study of 493 Bengali Hindu patients reported a significant association between the C allele and PDR in type 2 diabetes (*P*=0.0043), and a significant negative association between the TT genotype and PDR (*P*=0.0126).[@b44-opth-9-2175] An 11-study meta-analysis comprising six studies (1,654 patients of Asian and Caucasian backgrounds) also reported that the C allele was significantly associated with PDR (*P*=0.02) and DR (*P*=0.02) in type 2 diabetes.[@b45-opth-9-2175] Another 11-study meta-analysis including three relevant studies of the rs833061 polymorphism (746 patients of Asian background) also reported that rs833061 was significantly associated with DR in type 2 diabetes (*P*=0.02).[@b46-opth-9-2175] However, a study of 376 Han Chinese patients reported that the C allele was negatively associated with non-PDR (*P*=0.013), but there was no association with PDR.[@b47-opth-9-2175] A separate series of 500 Chinese patients reported no association with DR in type 2 diabetes.[@b48-opth-9-2175]

### rs699947 (−2578C/A)

A meta-analysis including eight studies (2,402 patients of Asian and European backgrounds) reported that rs699947 was significantly associated with DR in type 2 diabetes.[@b49-opth-9-2175] A study of 500 Chinese patients also reported that this polymorphism was significantly associated with DR in type 2 diabetes (OR =3.54, 95% CI =1.12--11.19).[@b48-opth-9-2175] A meta-analysis of 1,702 patients (1,124 of which were Asian) from six studies reported that rs699947 was significantly associated with DR in type 2 diabetes in Asian (*P*=0.0002) but not Caucasian patients.[@b50-opth-9-2175] A study of 148 Egyptian patients reported a significant association between this polymorphism and DR in patients having diabetes (type unspecified) for 20 years or more (*P*\<0.001).[@b51-opth-9-2175] However, a 6-study meta-analysis of 2,208 patients (both type 1 and type 2) from Caucasian and Asian backgrounds,[@b45-opth-9-2175] an 11-study meta-analysis including six relevant studies of 1,868 patients with type 2 diabetes from Caucasian and Asian backgrounds,[@b46-opth-9-2175] and a series of 1,040 Chinese patients with type 2 diabetes[@b52-opth-9-2175] reported no associations.

### rs2010963 \[(405G/C) and (634 G/C)\]

A study of 372 Bengali Hindu patients reported that the 405 C allele was significantly associated with PDR (*P*=0.0007) but not nonproliferative diabetic retinopathy (NPDR) in type 2 diabetes.[@b53-opth-9-2175] A meta-analysis comprising nine studies of 2,947 patients (mixed populations)[@b54-opth-9-2175] also reported a significant association of rs2010963 with DR in type 2 diabetes (*P*=0.03), but this result was refuted by a 7-study meta-analysis of 2,104 patients with type 2 diabetes of Asian and Caucasian backgrounds.[@b46-opth-9-2175]

### rs3025039 (+936C/T)

A meta-analysis including four studies and 1,147 Asian patients reported a significant association between rs3025039 and DR in type 2 diabetes (*P*=0.01).[@b46-opth-9-2175] A study of 372 Bengali Hindu patients reported that the T allele was significantly associated with PDR (*P*=0.0002) but not NDPR in type 2 diabetes.[@b53-opth-9-2175] A study of 1,040 Chinese patients also reported no association between +936C/T and DR in type 2 diabetes.[@b52-opth-9-2175]

### Other *VEGF* polymorphisms

A study of 2,567 French patients reported no association between the rs6921438 and rs10738760 polymorphisms and DR in type 2 diabetes.[@b55-opth-9-2175] A study of 500 Chinese patients reported a significant association between rs13207351 and DR in type 2 diabetes (OR =3.76, 95% CI =1.21--11.71).[@b48-opth-9-2175] In a series of 372 Bengali Hindu patients, no associations were reported between the rs1570360 (−1154 G/A) or rs2071559 (−604 A/G) polymorphisms and NPDR or PDR in type 2 diabetes.[@b53-opth-9-2175]

Newer candidate genes
=====================

Adiponectin
-----------

Adiponectin, encoded by *ADIPOQ*, is involved in regulating glucose levels as well as fatty acid breakdown.[@b56-opth-9-2175] The rs2241766 (T45G) polymorphism T allele of *ADIPOQ* was significantly associated with DR in type 2 diabetes in a study of 672 Punjab Indian patients (*P*=0.0007),[@b57-opth-9-2175] but not in a study of 517 Chinese patients.[@b58-opth-9-2175]

Complement factors H and B
--------------------------

Complement factors H (CFH) and B (CFB), both integral mediators of the alternative pathway of the immune system, have also been investigated.[@b59-opth-9-2175],[@b60-opth-9-2175] The *CFH* rs800292 (I62V) A allele was negatively associated with DR in a series of 552 Chinese patients with type 2 diabetes (*P*=0.04).[@b61-opth-9-2175] In the same series, the *CFB* rs1048709 (R150R) A allele was significantly associated with DR in type 2 diabetes (*P*=0.035).[@b61-opth-9-2175] In addition, the *CFH* rs1410996 polymorphism was not significantly associated with PDR in type 1 diabetes in a series of 147 Spanish patients.[@b62-opth-9-2175]

Chimerin 2
----------

Chimerin 2 activity is involved in cell migration and proliferation.[@b63-opth-9-2175] A study of 719 Han Chinese patients reported that the A allele of rs1002630 (OR =0.25, 95% CI =0.09--0.73) and the G allele of rs1362363 (OR =0.66, 95% CI =0.44--0.99) were both negatively associated with DR in type 2 diabetes.[@b64-opth-9-2175] A meta-analysis of two cohorts (Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications and Wisconsin Epidemiologic Study of Diabetic Retinopathy) comprising 1,907 patients reported no association between the rs39059 or rs39075 polymorphisms and DR in type 1 diabetes.[@b65-opth-9-2175]

Erythropoietin
--------------

Erythropoietin has been reported to stimulate angiogenesis, vasoconstriction-dependent hypertension, and smooth muscle fiber proliferation.[@b66-opth-9-2175] A series of 792 Chinese patients reported that the rs507392 and rs551238 CC genotypes were negatively associated with DR (*P*=0.027 and *P*=0.016, respectively) and PDR (*P*=0.002 and *P*=0.002, respectively) in type 2 diabetes.[@b67-opth-9-2175] However, other series reported no associations between erythropoietin polymorphisms and DR.[@b48-opth-9-2175],[@b65-opth-9-2175]

Glutathione S-transferase theta 1 and glutathione S-transferase mu 1
--------------------------------------------------------------------

Glutathione S-transferase theta 1 (GSTT1) and glutathione S-transferase mu 1 (GSTM1) neutralize toxins and products of oxidative stress.[@b68-opth-9-2175] A study of 604 Slovenian patients reported a significant association between the *GSTT1* null genotype and DR in type 2 diabetes (*P*\<0.001) and also reported that the *GSTM1* null genotype was negatively associated with DR in type 2 diabetes (*P*\<0.001).[@b69-opth-9-2175] A series of 115 Iranian patients reported a significant association between the *GSTM1* null genotype and DR in type 2 diabetes (*P*=0.04).[@b70-opth-9-2175] A meta-analysis of 3,463 subjects from multiple studies reported that both null genotypes were significantly associated with DR in type 1 and type 2 diabetes (*P*\<0.0001 for GSTT1 null genotype, *P*=0.0005 for GSTM1 null genotype).[@b71-opth-9-2175] However, a series of 605 Southern Iranian patients reported no associations between null genotypes in *GSTT1* or *GSTM1* and DR in type 2 diabetes.[@b72-opth-9-2175]

Intercellular adhesion molecule-1
---------------------------------

Intercellular adhesion molecule-1 (ICAM-1) binds integrins and is normally expressed by immune cells and endothelial cells; it participates in Class I major histocompatibility complex-mediated antigen processing/presentation.[@b73-opth-9-2175] The AA genotype of *ICAM-1* rs5498 (K469E) polymorphism was significantly associated with DR in a cohort of 356 South Indian patients with type 2 diabetes (*P*=0.012).[@b74-opth-9-2175] In addition, a meta-analysis of three studies comprising 1,232 Asian patients reported a significant negative association between the *ICAM-1* rs5498 (K469E) GG genotype and PDR in type 2 diabetes (*P*=0.016).[@b75-opth-9-2175] However, a series of 500 Chinese patients with type 2 diabetes,[@b48-opth-9-2175] a meta-analysis of seven studies including 3,411 Asian and Caucasian patients with type 2 diabetes,[@b76-opth-9-2175] and a meta-analysis of seven studies including 2,003 Asian and Caucasian patients with type 2 diabetes[@b77-opth-9-2175] have reported no associations between *ICAM-1* polymorphisms and DR.

Interferon gamma
----------------

Interferon gamma (IFN-γ) is a soluble cytokine with antiviral, immunoregulatory, and antitumor/antiproliferative properties and is a potent activator of macrophages.[@b78-opth-9-2175] A study of 493 Bengali Hindu Indians reported a significant association between the *IFN-γ* rs 2430561 (+874 T/A) T allele and PDR in type 2 diabetes (*P*=0.0011).[@b44-opth-9-2175] However, a study of 102 Brazilian patients reported no association between the same polymorphism and DR in type 2 diabetes.[@b79-opth-9-2175]

Interleukin-6 and interleukin-10
--------------------------------

Polymorphisms in interleukin-6 (IL-6) and interleukin-10 (IL-10) were also investigated. The rs1800896 (−1082) G allele in IL-10 was significantly associated with PDR in a study of 493 Bengali Hindu patients with type 2 diabetes (*P*=0.0048).[@b80-opth-9-2175] However, another study of 102 Brazilian patients reported that this polymorphism, plus two others in *IL-10* \[rs1800871 (−819 C/T) and rs1800872 (−592 C/A)\] and one in *IL-6* \[rs1800795 (−174 C/G)\], did not associate with DR in type 2 diabetes.[@b79-opth-9-2175]

Monocyte chemoattractant protein-1
----------------------------------

Monocyte chemoattractant protein-1 (MCP-1) is a chemokine specific for monocytes and basophils.[@b81-opth-9-2175] A series of 590 Korean patients reported a significant association between *MCP-1* rs1024611 (−2518 A/G) AA genotype and PDR in type 2 diabetes (*P*=0.009).[@b82-opth-9-2175] Alternatively, a study of 1,043 Han Chinese patients reported that the G allele of the same polymorphism was significantly associated with high-risk PDR in type 2 diabetes (*P*=0.02), although no association was reported with NDPR.[@b83-opth-9-2175] Two subsequent studies of 758 Japanese patients with type 2 diabetes (*P*=0.030)[@b84-opth-9-2175] and 517 Han Chinese patients with type 2 diabetes (*P*=0.026)[@b85-opth-9-2175] also reported that the G allele, not the A allele, was significantly associated with DR.

Manganese superoxide dismutase
------------------------------

Manganese superoxide dismutase binds superoxide byproducts from oxidative phosphorylation.[@b86-opth-9-2175] A study of 280 Northern Iranian patients reported that the A16V (C47T) polymorphism AV genotype was significantly associated with DR (*P*\<0.0001),[@b87-opth-9-2175] although a series of 758 Northern Indian patients reported no association between this polymorphism and DR in type 2 diabetes.[@b41-opth-9-2175]

Plasminogen activator inhibitor-1
---------------------------------

Plasminogen activator inhibitor-1 is the main inhibitor of tissue plasminogen activator and plays a major role in the regulation of intravascular fibrinolysis.[@b88-opth-9-2175] Impaired fibrinolysis is involved in the pathogenesis of DR in patients with type 2 diabetes.[@b89-opth-9-2175] A subgroup analysis of a meta-analysis comprising five studies of 1,936 Caucasian patients reported that the 675 4G/5G polymorphism was significantly associated with DR in type 2 diabetes (*P*=0.003); this association was not observed in the overall 9-study analysis of 2,676 patients of Caucasian, Asian, and Pima Indian backgrounds.[@b90-opth-9-2175] A separate meta-analysis comprising ten studies of 5,768 type 1 and type 2 diabetic patients of Asian and European descents, respectively, reported no significant associations with DR.[@b91-opth-9-2175]

Peroxisome proliferator-activated receptor gamma
------------------------------------------------

Peroxisome proliferator-activated receptor gamma is a regulator of adipocyte differentiation[@b92-opth-9-2175] and has been implicated in the pathology of obesity, diabetes, and other disorders.[@b93-opth-9-2175] A meta-analysis comprising eight studies of 5,170 Caucasian and Asian patients reported that the rs1801282 (Pro12Ala) polymorphism Ala allele was negatively associated with DR in type 2 diabetes in Caucasians only (*P*=0.01).[@b94-opth-9-2175] Similarly, a series of 573 Pakistani patients also reported a significant negative association between the Ala allele and PDR in type 2 diabetes (OR =0.4, 95% CI =0.2--0.8).[@b95-opth-9-2175] However, a series of 1,907 patients from the US with type 1 diabetes,[@b65-opth-9-2175] a series of 2,963 Finnish patients with type 1 diabetes,[@b96-opth-9-2175] and a series of 792 Chinese patients with type 2 diabetes[@b97-opth-9-2175] reported no associations.

Transcription factor 7-like 2
-----------------------------

Variants of transcription factor 7-like 2, a protein involved in blood glucose homeostasis, are associated with increased risk for type 2 diabetes.[@b98-opth-9-2175] A series of 325 Italian patients reported significant associations between the rs7903146 (*P*=0.037) and rs12255372 (*P*=0.014) polymorphisms and DR in type 2 diabetes.[@b99-opth-9-2175] A study of 1,139 Caucasian patients with type 2 diabetes and 789 Caucasian patients with type 1 diabetes reported a significant association between the rs7903146 T allele and PDR in type 2 patients only (*P*=0.001).[@b100-opth-9-2175] However, a series of 1,129 Chinese patients with type 2 diabetes,[@b101-opth-9-2175] a series of 2,963 Finnish patients with type 1 diabetes,[@b96-opth-9-2175] a series of 792 Chinese patients with type 2 diabetes,[@b97-opth-9-2175] and a meta-analysis of over 1,000 patients from multiple backgrounds with type 2 diabetes[@b102-opth-9-2175] reported no associations.

Transforming growth factor beta 1
---------------------------------

Transforming growth factor beta 1 is involved in many cellular functions such as proliferation and differentiation.[@b103-opth-9-2175],[@b104-opth-9-2175] A study of 102 Brazilians reported that the rs1800471 (R25P) G allele was significantly associated with DR in type 2 diabetes (*P*=0.018).[@b79-opth-9-2175] A meta-analysis of 1,101 patients including patients from multiple ethnic groups reported that the rs1982073 (T869C) L allele was negatively associated with DR in type 2 diabetes (*P*=0.03).[@b105-opth-9-2175] However, a study of 361 British Caucasian patients reported no significant associations between the rs1982073 (T869C) or rs1800471 (R25P) polymorphisms and DR in type 1 diabetes.[@b106-opth-9-2175]

Toll-like receptor 4
--------------------

Toll-like receptor 4 helps mediate the innate immune response and has been associated with age-related macular degeneration[@b107-opth-9-2175],[@b108-opth-9-2175] and Behçet's disease. In two series, one of 698 North Indian patients and one of 510 Han Chinese patients, the rs1927914 (TLR4_2437) polymorphism was significantly associated with DR in type 2 diabetes (*P*=0.05, *P*=0.018, respectively).[@b109-opth-9-2175],[@b110-opth-9-2175] The study of 698 North Indian patients also reported a significant association between the rs10759931 (TLR4_2437) AG genotype and DR in type 2 diabetes.[@b109-opth-9-2175]

Tumor necrosis factor alpha
---------------------------

Tumor necrosis factor alpha (TNF-α) is involved in the regulation of processes like cell proliferation, differentiation, apoptosis, lipid metabolism, and blood vessel permeability.[@b111-opth-9-2175] A series of 745 Brazilian-Caucasian patients reported that the rs1800629 (TNF-308 G/A) A allele was significantly associated with PDR in type 2 diabetes (*P*=0.035).[@b112-opth-9-2175] Similarly, a study of 493 Bengali Hindu patients reported that the rs361525 (TNF-238) A allele was significantly associated with PDR in type 2 diabetes (*P*=0.0001).[@b80-opth-9-2175] However, a study of 672 Punjab Indian patients with type 2 diabetes,[@b57-opth-9-2175] a series of 102 Brazilian patients with type 2 diabetes,[@b79-opth-9-2175] and a meta-analysis of 3,041 patients from Europe and Asia with type 2 diabetes[@b113-opth-9-2175] reported no associations between the rs1800629 (TNF-308 G/A) polymorphism and DR.

Uncoupling proteins 1 and 2
---------------------------

Uncoupling proteins 1 and 2 (UCP1 and UCP2) are involved in regulation of cellular metabolism.[@b114-opth-9-2175] A study of 257 Brazilian patients reported that the rs1800592 (−3826A/G) GG genotype of *UCP1* was significantly associated with DR in type 1 diabetes (*P*=0.043).[@b115-opth-9-2175] A series of 792 Chinese patients reported that the rs1800592 (−3826A/G) GG genotype of *UCP1* was significantly associated with PDR (*P*=0.03) but not NPDR in type 2 diabetes.[@b97-opth-9-2175] A separate series of 958 Chinese patients reported that the rs659366 G allele of *UCP2* was significantly associated with PDR (*P*=0.016) but not NPDR in type 2 diabetes.[@b116-opth-9-2175]

Candidate genes with no reported associations
=============================================

Hematopoietically expressed homeobox
------------------------------------

Hematopoietically expressed homeobox is involved in embryogenesis, cellular transcriptional misregulation, and pancreatic β-cell development.[@b117-opth-9-2175] Two studies investigated the rs7923837 polymorphism in 1,129 type 2 diabetic Chinese patients[@b101-opth-9-2175] and rs1111875 polymorphisms in 2,963 type 1 diabetic Finnish patients,[@b96-opth-9-2175] respectively, and reported no associations with DR.

Solute carrier family
---------------------

Solute carrier family (SLC) proteins are expressed mainly in the pancreatic islets of Langerhans and play a role in insulin secretion.[@b118-opth-9-2175] A series of 1,129 Chinese patients with type 2 diabetes,[@b101-opth-9-2175] a series of 2,963 Finnish patients with type 1 diabetes,[@b96-opth-9-2175] a series of 211 Malaysian patients with type 2 diabetes,[@b119-opth-9-2175] and a series of 6,682 patients from Singapore with type 2 diabetes[@b120-opth-9-2175] reported no associations between *SLC* and DR.

In addition to the genes discussed above, many other polymorphisms have been studied. [Table 4](#t4-opth-9-2175){ref-type="table"} summarizes these relatively new candidate genes that may have bearing on DR.

Discussion
==========

Many individual studies have reported statistically significant associations between various polymorphisms and features of DR. However, many of the results are conflicting and it is difficult to draw definitive conclusions based on the available literature. At this time, there is no confirmed association with any risk allele reported. This may be due to a variety of reasons.

There are multiple challenges in designing a genetic association study, especially with respect to DR. The genetic contribution to DR appears to be relatively modest, requiring larger sample sizes to achieve sufficient statistical power. Determining the number of patients required to achieve sufficient statistical power is complex and is best performed by statisticians or those with experience in this area. In at least some of the studies reviewed here, it is not certain how (or if) power calculations were performed.

Further, DR is a qualitative trait that cannot be easily reduced to a numerical value. The modified Airlie House Classification is a numerical system based on stereoscopic photographs of seven standard fields, resulting in a grade ranging from 10 (no retinopathy) to 85 (severe vitreous hemorrhage or retinal detachment involving the macula).[@b121-opth-9-2175] However, this complex classification system is rarely used today. Specific clinical end points such as any DR, NPDR, PDR, or diabetic macular edema may differ across studies. In addition, some patients have retinal changes that mimic early DR, which may further confound studies.[@b122-opth-9-2175],[@b123-opth-9-2175]

Type 2 diabetes mellitus is associated with relatively late disease onset as well as reduced life span, so the parents of patients may not be available for study.[@b3-opth-9-2175] There is likely substantial heterogeneity within individual studies, including duration of diabetes, age at first diagnosis (if known), strictness of metabolic control, and comorbidities such as hypertension, hypercholesterolemia, and others. In addition, there is likely substantial heterogeneity across different studies, due to underlying differences in study populations.

Different studies were conducted on different continents with patients of different races and ethnicities. Further, multiple meta-analyses combined these studies in different ways. Some studies used self-reported data, which may introduce bias because patients may be more likely to report severe retinopathy as opposed to milder disease.[@b124-opth-9-2175]

At this time, genetic associations with DR are an intriguing area of research, but are not helpful in routine clinical management. As we collect more information about genotype--phenotype correlations, our understanding may increase. Ultimately, this information may help to stratify patients into different risk groups, which may positively impact clinical management decisions. In addition, this information may lead to the investigation of future drug targets.
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###### 

Well-studied candidate gene studies and findings

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene     Polymorphism                                                                      Relation to diabetic retinopathy and significance level                                             Population and size (number of participants)                                                                                   Methodology (self-reported vs clinically assessed)                                                          References
  -------- --------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------- --------------------
  *AR*     C(−106)T, specifically\                                                           Positive assn w/DR in T2DM (*P*=0.03)                                                               Iranian (206 pts)                                                                                                              Clinically assessed                                                                                         [@b27-opth-9-2175]
           CC genotype                                                                                                                                                                                                                                                                                                                                                                                                                      

           C(−106)T                                                                          No sig assn w/DR in T2DM                                                                            Chinese (268 pts)                                                                                                              Clinically assessed                                                                                         [@b28-opth-9-2175]

           C(−106)T, C allele                                                                No sig assn w/NPDR or PDR in T2DM\                                                                  Meta-analysis of 17 studies including multiple populations (7,831 pts)                                                         Clinically assessed in all included studies except two, which did not report how DR was determined in pts   [@b29-opth-9-2175]
                                                                                             Positive assn w/DR in T1DM (OR =1.78, 95% CI =1.39--2.28)                                                                                                                                                                                                                                                                                      

  *eNOS*   VNTR 4b/a, a allele                                                               Negative assn w/DR (8 studies = T2DM, 1 study = T1DM; *P*=0.005); no sig assn w/PDR                 9 studies for NOS3 4b/a polymorphism (3,145 pts)                                                                               Not reported                                                                                                [@b31-opth-9-2175]

           rs2070744 (786T/C)                                                                No sig assn w/DR or PDR (4 studies = T2DM, 1 study = T1DM)                                          5 studies for NOS3 T-786C polymorphism (2,147 pts)                                                                                                                                                                                         

           rs1799983 (894G/T, also Glu298Asp)                                                No sig assn w/DR or PDR in T2DM                                                                     7 studies for NOS3 G894T polymorphism (2,819 pts) Meta-analysis of 12 studies including multiple populations (8,111 pts)                                                                                                                   

           VNTR 4b/a, aa genotype                                                            Negative assn w/PDR (*P*=0.03) but no sig assn w/DR in T2DM                                         Asian Indian (1,446 pts)                                                                                                       Clinically assessed                                                                                         [@b32-opth-9-2175]

           rs2070744 (786T/C), CC genotype rs1799983 (894G/T, also Glu298Asp), TT genotype   No sig assn w/DR or PDR in T2DM\                                                                                                                                                                                                                                                                                                               
                                                                                             No sig assn w/DR or PDR in T2DM                                                                                                                                                                                                                                                                                                                

           VNTR 4b/a, aa genotype                                                            Negative assn w/DR in T2DM (OR =0.75, 95% CI =0.65--0.88) in Africans (2 studies) but not\          Meta-analysis of 16 studies including multiple populations (6,664 pts)                                                         Not reported                                                                                                [@b33-opth-9-2175]
                                                                                             Caucasians (4 studies) or Asians (10 studies)                                                                                                                                                                                                                                                                                                  

           VNTR 4b/a, a allele                                                               Positive assn w/PDR in T2DM (*P*=0.01)                                                              Slovenian (577 pts)                                                                                                            Clinically assessed                                                                                         [@b34-opth-9-2175]

           rs1799983 (894G/T, also Glu298Asp), GG genotype                                   No sig assn w/PDR in T2DM                                                                                                                                                                                                                                                                                                                      

           VNTR 4b/a, aa genotype                                                            No sig assn w/DR or PDR in T2DM                                                                     Caucasian-Brazilian (630 pts)                                                                                                  Clinically assessed                                                                                         [@b35-opth-9-2175]

           rs2070744 (786T/C) genotype rs1799983 (894G/T, also Glu298Asp) genotype           No sig assn w/DR or PDR in T2DM\                                                                                                                                                                                                                                                                                                               
                                                                                             No sig assn w/DR or PDR in T2DM                                                                                                                                                                                                                                                                                                                

           VNTR 4b/a, aa genotype\                                                           No sig assn w/DR in T2DM No sig assn w/DR in T2DM No sig assn w/DR in T2DM                          South Indian (311 pts)                                                                                                         Clinically assessed                                                                                         [@b36-opth-9-2175]
           rs2070744 (786T/C) genotype\                                                                                                                                                                                                                                                                                                                                                                                                     
           rs1799983 (894G/T, also Glu298Asp) genotype                                                                                                                                                                                                                                                                                                                                                                                      

           VNTR 4b/a genotype                                                                No sig assn w/DR in T2DM                                                                            Meta-analysis of 15 studies including multiple populations (6,593 pts)                                                         Not reported                                                                                                [@b37-opth-9-2175]

  *RAGE*   −429T/C in promoter region\                                                       No sig assn w/DR in T2DM\                                                                           Malaysian (577 pts)                                                                                                            Clinically assessed                                                                                         [@b39-opth-9-2175]
           −374T/A in promoter region                                                        No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                       

           −429T/C in promoter region\                                                       No sig assn w/DR in T2DM\                                                                           Asian and Caucasian -- 6 studies (2,317 pts)\                                                                                  Clinically assessed                                                                                         [@b40-opth-9-2175]
           −374T/A in promoter region, AA genotype\                                          Negative assn w/DR in T2DM (OR =0.64, 95% CI =0.42--0.99)\                                          Asian, African, and Caucasian -- 7 studies (3,339 pts)\                                                                                                                                                                                    
           Gly82Ser, 82S allelic variant                                                     No sig assn w/DR in T2DM                                                                            Asian -- 5 studies (1,911 pts) (meta-analysis of 11 studies)                                                                                                                                                                               

           Gly82Ser, Ser82 genotype                                                          Sig assn w/DR in T2DM (*P*\<0.033)                                                                  North Indian (758 pts)                                                                                                         Clinically assessed                                                                                         [@b41-opth-9-2175]

           Gly82Ser in exon 3\                                                               No sig assn w/DR in T2DM\                                                                           Malaysian (283 pts)                                                                                                            Clinically assessed                                                                                         [@b42-opth-9-2175]
           1704 G/T in intron 7\                                                             No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                                                      
           2184 A/G in intron 8                                                              No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                       

           Gly82Ser in exon 3\                                                               No sig assn w/DR in T2DM\                                                                           Caucasian, Asian, African American (meta-analysis of 29 studies -- 1000+ pts)                                                  Not reported                                                                                                [@b43-opth-9-2175]
           1704 G/T in intron 7\                                                             No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                                                      
           429T/C in promoter region                                                         No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                       

  *VEGF*   rs833061 (−460 C/T)\                                                              Positive assn w/PDR in T2DM (*P*=0.0043)\                                                           Asian (Indian, Bengali Hindu -- 493 pts)                                                                                       Clinically assessed                                                                                         [@b44-opth-9-2175]
           C allele rs833061 (−460 C/T) TT genotype                                          Negative assn w/PDR in T2DM (*P*=0.0126)                                                                                                                                                                                                                                                                                                       

           rs699947 (−2578 A/C)\                                                             No sig assn w/DR in DM (studies include T1DM + T2DM)\                                               Asian and Caucasian: 6 studies (2,208 pts)\                                                                                    Clinically assessed                                                                                         [@b45-opth-9-2175]
           rs833061 (−460T/C) C allele                                                       Positive assn w/DR (*P*=0.02) and PDR (*P*=0.02) in T2DM                                            Asian and Caucasian: 6 studies (1,654 pts) (meta-analysis of 11 studies; one study examined both SNPs)                                                                                                                                     

           rs2010963 (−634G/C)\                                                              No sig assn w/DR in T2DM\                                                                           Asian and Caucasian: 7 studies (2,104 pts)\                                                                                    Not reported                                                                                                [@b46-opth-9-2175]
           rs699947 (−2578C/A)\                                                              No sig assn w/DR in T2DM\                                                                           Asian and Caucasian: 6 studies (1,868 pts)\                                                                                                                                                                                                
           rs3025039 (+936C/T)\                                                              Positive assn w/DR in T2DM (*P*=0.01)\                                                              Asian only: 4 studies (1,147 pts)\                                                                                                                                                                                                         
           rs833061 (−460T/C)                                                                Positive assn w/DR in T2DM (*P*=0.02)                                                               Asian only: 3 studies (746 pts) (meta-analysis of 11 studies)                                                                                                                                                                              

           rs2010963 (−634 G/C)\                                                             No sig assn w/DR/PDR in T2DM\                                                                       Han Chinese (376 pts)                                                                                                          Clinically assessed                                                                                         [@b47-opth-9-2175]
           rs833061 (−460 C/T)\                                                              Negative assn w/NPDR (*P*=0.013 for genotype, *P*=0.002 for allele) but no sig assn w/PDR in T2DM                                                                                                                                                                                                                                              
           C allele/CC genotype                                                                                                                                                                                                                                                                                                                                                                                                             

           rs699947 (−2578C/A)\                                                              Positive assn w/DR in T2DM (OR =3.54, 95% CI =1.12--11.19)\                                         Chinese (500 pts)                                                                                                              Clinically assessed                                                                                         [@b48-opth-9-2175]
           rs13207351\                                                                       Positive assn w/DR in T2DM (OR =3.76, 95% CI =1.21--11.71)\                                                                                                                                                                                                                                                                                    
           rs833061 (−460 C/T)\                                                              No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                                                      
           rs2146323                                                                         No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                       

           rs699947 (−2578 A/C)\                                                             Positive assn w/DR (type not specified) in T2DM (*P*=0.003)\                                        Asians and Europeans: 8 studies (2,402 pts) Asians and Europeans: 10 studies (3,448 pts) (meta-analysis of 18 studies total)   Not reported                                                                                                [@b49-opth-9-2175]
           rs2010963 (+405 G/C)                                                              No sig assn w/DR or PDR in T2DM                                                                                                                                                                                                                                                                                                                

           rs699947 (−2578C/A) AA genotype                                                   Positive assn w/DR in T2DM in\                                                                      Asian and Caucasian (meta-analysis of 6 studies -- 1,702 pts; 1,124 of which were Asian)                                       Not reported                                                                                                [@b50-opth-9-2175]
                                                                                             Asian (*P*=0.0002) pts but not in Caucasian pts                                                                                                                                                                                                                                                                                                

           rs699947 (−2578 A/C)                                                              No sig assn w/DR unless diabetes duration of 20+ years (*P*\<0.001) (Type of DM not specified)      Egyptian (148 pts)                                                                                                             Clinically assessed                                                                                         [@b51-opth-9-2175]

           rs699947 (−2578 A/C)\                                                             No sig assn w/DR in T2DM\                                                                           Chinese (1,040 pts)                                                                                                            Clinically assessed                                                                                         [@b52-opth-9-2175]
           rs2010963 (+405C/G)\                                                              No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                                                      
           rs3025039 (+936C/T)                                                               No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                       

           rs1570360 (−1154 G/A)                                                             No sig assn w/NPDR or PDR in T2DM                                                                   Bengali Hindu (372 pts)                                                                                                        Clinically assessed                                                                                         [@b53-opth-9-2175]

           rs3025039 (+936 C/T)\                                                             Positive assn w/PDR (*P*=0.0002) but not NPDR in T2DM\                                                                                                                                                                                                                                                                                         
           T allele\                                                                         Positive assn w/PDR (*P*=0.0007) but not w/NPDR in T2DM\                                                                                                                                                                                                                                                                                       
           rs2010963 (+405 G/C)\                                                             No sig assn w/NPDR or PDR in T2DM                                                                                                                                                                                                                                                                                                              
           C allele\                                                                                                                                                                                                                                                                                                                                                                                                                        
           rs2071559 (R 2/KDR-604 A/G)                                                                                                                                                                                                                                                                                                                                                                                                      

           rs2010963 (−634G/C) C allele                                                      Positive assn w/DR in T2DM (*P*=0.03)                                                               Meta-analysis of 9 studies including multiple populations (2,947 pts)                                                          Clinically assessed                                                                                         [@b54-opth-9-2175]

           rs6921438\                                                                        No sig assn w/DR in T2DM\                                                                           French (2,567 pts)                                                                                                             Clinically assessed                                                                                         [@b55-opth-9-2175]
           rs10738760                                                                        No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                       
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** AR, aldose reductase; eNOS, endothelial nitric oxide synthase; VNTR, variable number tandem repeat; RAGE, receptor for advanced glycation end products; VEGF, vascular endothelial growth factor; PDR, proliferative diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; KDR, kinase insert domain receptor; T2DM, type 2 diabetes mellitus; T1DM, type 1 diabetes mellitus; SNP, single nucleotide polymorphism; DR, diabetic retinopathy; OR, odds ratio; CI, confidence interval; assn, association; sig, significant; pts, participants; w/, with.

###### 

Newer candidate gene studies and findings

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                     Polymorphism                                            Relation to diabetic retinopathy and significance level                                                  Population and size (number of participants)                                                                                             Methodology (self-reported vs clinically assessed)      References
  ------------------------ ------------------------------------------------------- -------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------- ---------------------
  Adiponectin (*ADIPOQ*)   rs2241766 (T45G) T allele                               Positive assn w/DR in T2DM (*P*=0.0007)                                                                  Indian -- NW population of Punjab -- (672 pts)                                                                                           Clinically assessed                                     [@b57-opth-9-2175]

                           rs266729 (C-11377G)\                                    No sig assn w/DR in T2DM\                                                                                Chinese (517 pts)                                                                                                                        Clinically assessed                                     [@b58-opth-9-2175]
                           rs822394 (A-4034C)\                                     No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs1501299 (G276T)\                                      No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs2241766 (T45G)                                        No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

  *CFH* and *CFB*          rs1048709 (R150R)\                                      Positive assn w/DR in T2DM (*P*=0.035)\                                                                  Chinese (552 pts)                                                                                                                        Clinically assessed                                     [@b61-opth-9-2175]
                           A allele in CFB\                                        Negative assn w/DR in T2DM (*P*=0.04)\                                                                                                                                                                                                                                                                    
                           rs800292 (I62V) A allele in CFH\                        No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs537160 (IVS7)\                                        No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           G \> A in CFB\                                          No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  
                           rs4151657 (IVS10) T \> C in CFB\                                                                                                                                                                                                                                                                                                                                  
                           rs2072633 (IVS17) A \> G in CFB                                                                                                                                                                                                                                                                                                                                   

                           rs1410996                                               No sig assn w/PDR in T1DM                                                                                Spanish (147 pts)                                                                                                                        Clinically assessed                                     [@b62-opth-9-2175]

  *CHN2*                   rs1002630 A allele\                                     Negative assn w/NPDR (OR =0.25, 95% CI =0.09--0.73) but not w/PDR in T2DM\                               Taiwanese -- Han Chinese -- (719 pts)                                                                                                    Clinically assessed                                     [@b64-opth-9-2175]
                           rs1362363 G allele\                                     Negative assn w/DR (NPDR + PDR) in T2DM (OR =0.66, 95% CI =0.44--0.99)\                                                                                                                                                                                                                                   
                           rs39059\                                                No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs2023908                                               No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

                           rs39059\                                                No sig assn w/DR in T1DM\                                                                                US, demographics not reported (1,907 pts)                                                                                                Clinically assessed                                     [@b65-opth-9-2175]
                           rs39075                                                 No sig assn w/DR in T1DM                                                                                                                                                                                                                                                                                  

  *EPO*                    rs507392 CC genotype\                                   Negative assn w/DR (*P*=0.027) and PDR (*P*=0.002) in T2DM\                                              Chinese (792 pts)                                                                                                                        Clinically assessed                                     [@b67-opth-9-2175]
                           rs551238 CC genotype\                                   Negative assn w/DR (*P*=0.016) and PDR (*P*=0.002) in T2DM\                                                                                                                                                                                                                                               
                           rs1617640                                               No sig assn between NDR or PDR in T2DM                                                                                                                                                                                                                                                                    

                           rs551238\                                               No sig assn w/DR in T2DM\                                                                                Chinese (500 pts)                                                                                                                        Clinically assessed                                     [@b48-opth-9-2175]
                           rs1617640                                               No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

                           rs1617640                                               No sig assn w/DR in T1DM                                                                                 US, demographics not reported (1,907 pts)                                                                                                Clinically assessed                                     [@b65-opth-9-2175]

  *GSTT1* and *GSTM1*      Null genotype in GSTT1\                                 Positive assn w/DR\                                                                                      Slovenian (604 pts)                                                                                                                      Clinically assessed                                     [@b69-opth-9-2175]
                           Null genotype in GSTM1                                  (NPDR + PDR) in T2DM (*P*\<0.001)\                                                                                                                                                                                                                                                                        
                                                                                   Negative assn w/DR in T2DM (*P*\<0.001)                                                                                                                                                                                                                                                                   

                           Null genotype in GSTT1\                                 No sig assn w/DR in T2DM\                                                                                Iranian (115 pts)                                                                                                                        Clinically assessed                                     [@b70-opth-9-2175]
                           Null genotype in GSTM1                                  Positive assn w/DR in T2DM (*P*=0.04)                                                                                                                                                                                                                                                                     

                           Null genotype in GSTT1\                                 Positive assn w/DR (4 studies = T2DM, 1 study = T1DM; *P*\<0.0001)\                                      Caucasian (meta-analysis of 5 studies -- report 3,563 pts, but actually comprise 3,463 pts based on studies included in meta-analysis)   Not reported                                            [@b71-opth-9-2175]
                           Null genotype in GSTM1                                  Positive assn w/DR (3 studies = T2DM, 1 study = T1DM; *P*=0.0005)                                                                                                                                                                                                                                         

                           Null genotype in GSTT1\                                 No sig assn w/DR in T2DM\                                                                                Southern Iranian (605 pts)                                                                                                               Clinically assessed                                     [@b72-opth-9-2175]
                           Null genotype in GSTM1                                  No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

  *ICAM*-*1*               rs5498 (K469E) AA genotype                              Positive assn w/DR in T2DM (*P*=0.012)                                                                   South Indian (356 pts)                                                                                                                   Clinically assessed                                     [@b74-opth-9-2175]

                           rs5498 (K469E) (GG + AG vs AA)                          Negative assn w/PDR in T2DM in Asian pts only (*P*=0.016); no sig assn w/DR in T2DM                      Asian (meta-analysis of 7 studies -- 2076 pts); assn w/PDR was found using 3 studies comprising 1,232 pts                                Clinically assessed                                     [@b75-opth-9-2175]

                           rs1799969 (G241R or +241G/A)                            No sig assn w/DR in T2DM                                                                                 Chinese (500 pts)                                                                                                                        Clinically assessed                                     [@b48-opth-9-2175]

                           rs5498 (K469E)                                          No sig assn w/DR in DM (T1 and T2)                                                                       4 Asian and 3 Caucasian (meta-analysis of 7 studies -- 3,411 pts)                                                                        Not reported                                            [@b76-opth-9-2175]

                           rs5498 (K469E)                                          No sig assn w/DR in T2DM                                                                                 6 Asian +1 Caucasian study (meta-analysis of 7 studies -- 2,003 pts)                                                                     Not reported                                            [@b77-opth-9-2175]

  *IFN*-*γ*                rs2430561 (+874 T/A) T allele                           Positive assn w/PDR in T2DM (*P*=0.0011)                                                                 Asian (Indian, Bengali Hindu -- 493 pts)                                                                                                 Clinically assessed                                     [@b44-opth-9-2175]

                           rs2430561 (+874 T/A)                                    No sig assn w/DR in T2DM                                                                                 Brazilian (102 pts)                                                                                                                      Clinically assessed                                     [@b79-opth-9-2175]

  *IL*-*6* and *IL*-*10*   rs1800896 (−1082) G allele in IL-10\                    Positive assn w/PDR in T2DM (*P*=0.0048)\                                                                Bengali Hindu (493 pts)                                                                                                                  Clinically assessed                                     [@b80-opth-9-2175]
                           rs1800795 (−174G/C) in IL-6                             No sig assn w/PDR in T2DM                                                                                                                                                                                                                                                                                 

                           rs1800896 (−1082 G/A) in IL-10\                         No sig assn w/DR in T2DM\                                                                                Brazilian (102 pts)                                                                                                                      Clinically assessed                                     [@b79-opth-9-2175]
                           rs1800871 (−819C/T) in IL-10\                           No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs1800872 (−592C/A) in IL-10\                           No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs1800795 (−174C/G) in IL-6                             No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

  *MCP*-*1*                rs1024611 (−2518 A/G) AA genotype                       Positive assn w/PDR in T2DM (*P*=0.009)                                                                  Korean (590 pts)                                                                                                                         Clinically assessed                                     [@b82-opth-9-2175]

                           rs1024611 (−2518 A/G) G allele                          Positive assn w/PDR (*P*=0.02) but not NPDR in T2DM                                                      Han Chinese (1,043 pts)                                                                                                                  Clinically assessed                                     [@b83-opth-9-2175]

                           rs1024611 (−2518 A/G) G allele                          Increased onset of DR associated w/increased number of G alleles in T2DM (*P*=0.030)                     Japanese (758 pts)                                                                                                                       Clinically assessed                                     [@b84-opth-9-2175]

                           rs1024611 (−2518 A/G) G allele                          Positive assn w/PDR (*P*=0.007) and NPDR (*P*=0.026) in T2DM                                             Han Chinese (517 pts)                                                                                                                    Clinically assessed                                     [@b85-opth-9-2175]

  *MnSOD*                  A16V (C47T) AV genotype                                 Positive assn w/DR (*P*\<0.0001) \[Type of DM not specified in abstract, original article in Russian\]   North Iranian (280 pts)                                                                                                                  Not reported in abstract, original article in Russian   [@b87-opth-9-2175]

                           A16V (C47T)                                             No sig assn w/DR in T2DM                                                                                 North Indian (758 pts)                                                                                                                   Clinically assessed                                     [@b41-opth-9-2175]

  *PAI*-*1*                −675 4G/5G, 4G4G genotype                               Positive assn w/DR in T2DM in Caucasians (*P*=0.003) but not Asians                                      Caucasian, Asian, and Pima Indians (meta- analysis of 9 studies -- 2,676 pts)                                                            Not reported                                            [@b90-opth-9-2175]

                           −675 4G/5G                                              No sig assn w/DR in T1DM (Asian descent) or in T2DM (European descent)                                   Asian and European (meta-analysis of 10 studies -- 5,768 pts)                                                                            Not reported                                            [@b91-opth-9-2175]

  *PPARγ*                  rs1801282 (Pro12Ala) 12Ala allele                       Negative assn w/DR in T2DM in Caucasian subgroup (*P*=0.01) but not in Asian subgroup (*P*=0.12)         6 Caucasian studies and 2 Asian studies (meta-analysis of 8 studies -- 5,170 pts)                                                        Clinically assessed                                     [@b94-opth-9-2175]

                           rs1801282 (Pro12Ala) 12Ala allele                       Negative assn w/PDR (OR =0.4, 95% CI =0.2--0.8) but not NPDR in T2DM                                     Pakistani (573 pts)                                                                                                                      Clinically assessed                                     [@b95-opth-9-2175]

                           rs1801282 (Pro12Ala)\                                   No sig assn w/DR or PDR in T2DM\                                                                         Chinese (792 pts)                                                                                                                        Clinically assessed                                     [@b97-opth-9-2175]
                           rs3856806\                                              No sig assn w/DR or PDR in T2DM\                                                                                                                                                                                                                                                                          
                           rs12497191                                              No sig assn w/DR or PDR in T2DM                                                                                                                                                                                                                                                                           

                           rs1801282 (Pro12Ala)                                    No sig assn w/DR in T1DM                                                                                 US, demographics not reported (1,907 pts)                                                                                                Clinically assessed                                     [@b65-opth-9-2175]

                           rs1801282 (Pro12Ala)                                    No sig assn w/DR in T1DM                                                                                 Finnish (2,963 pts)                                                                                                                      Clinically assessed                                     [@b96-opth-9-2175]

  *TCF7L2*                 rs7903146\                                              Positive assn w/DR in T2DM (*P*=0.037)\                                                                  Italian (325 pts)                                                                                                                        Clinically assessed                                     [@b99-opth-9-2175]
                           rs12255372\                                             Positive assn w/DR in T2DM (*P*=0.014)\                                                                                                                                                                                                                                                                   
                           rs7901695                                               No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

                           rs7903146 T allele                                      Positive assn w/PDR in T2DM (*P*=0.001) but not in T1DM                                                  Caucasian (1,139 T2DM pts and 789 T1DM pts)                                                                                              Clinically assessed                                     [@b100-opth-9-2175]

                           rs7903146                                               No sig assn w/DR in T2DM                                                                                 African Americans, Caucasians, Polish, and Asian (review of 3 studies +1 abstract -- 1,000+ pts)                                         Not reported                                            [@b102-opth-9-2175]

                           rs6585205\                                              No sig assn w/DR in T2DM\                                                                                Chinese (1,129 pts)                                                                                                                      Not reported in abstract, original article in Chinese   [@b101-opth-9-2175]
                           rs7903146\                                              No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs11196218                                              No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

                           rs7903146                                               No sig assn w/DR in T1DM                                                                                 Finnish (2,963 pts)                                                                                                                      Clinically assessed                                     [@b96-opth-9-2175]

                           rs11196205                                              No sig assn w/DR or PDR in T2DM                                                                          Chinese (792 pts)                                                                                                                        Clinically assessed                                     [@b97-opth-9-2175]

  *TGF*-*β1*               rs1800471 (R25P) (+915G/C) G allele rs1982073 (T869C)   Positive assn w/DR in T2DM (*P*=0.018)\                                                                  Brazilian (102 pts)                                                                                                                      Clinically assessed                                     [@b79-opth-9-2175]
                                                                                   No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

                           rs1982073 (T869C) (L10P) L allele\                      Negative assn w/DR in T2DM (*P*=0.03) No sig assn w/DR in T2DM No sig assn w/DR in T2DM                  Czech, Polish, and Indian (meta-analysis of 3 studies -- 1,101 pts total)                                                                Clinically assessed                                     [@b105-opth-9-2175]
                           rs1800469 (−509 C/T)\                                                                                                                                                                                                                                                                                                                                             
                           rs1800468 (−800 G/A)                                                                                                                                                                                                                                                                                                                                              

                           rs1982073 (T869C)\                                      No sig assn w/DR in T1DM\                                                                                Caucasian (British -- 361 pts)                                                                                                           Clinically assessed                                     [@b106-opth-9-2175]
                           rs1800471 (R25P)\                                       No sig assn w/DR in T1DM                                                                                                                                                                                                                                                                                  
                           (+915G/C)                                                                                                                                                                                                                                                                                                                                                         

  *TLR4*                   rs4986790 (Asp299Gly)\                                  No sig assn w/DR in T2DM\                                                                                North Indian (698 pts)                                                                                                                   Clinically assessed                                     [@b109-opth-9-2175]
                           rs4986791 (Thr399Ile)\                                  No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                           rs10759931 (TLR4_1859) AG genotype\                     Positive assn w/DR in T2DM (*P*=0.04)\                                                                                                                                                                                                                                                                    
                           rs1927914 (TLR4_2437) TC genotype\                      Positive assn w/DR in T2DM (*P*=0.05)\                                                                                                                                                                                                                                                                    
                           rs1927911 (TLR4_7764)                                   No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

                           rs1927914 C allele rs10759931 (TLR4_1859)\              Positive assn w/DR in T2DM (*P*=0.018)\                                                                  Han Chinese (510 pts)                                                                                                                    Clinically assessed                                     [@b110-opth-9-2175]
                           rs1927911 (TLR4_7764)                                   No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                 
                                                                                   No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                  

  *TNF*-*α*                rs1800629 (TNF-308 G/A) A allele                        Positive assn w/PDR in T2DM (*P*=0.035)                                                                  Caucasian-Brazilian (745 pts)                                                                                                            Clinically assessed                                     [@b112-opth-9-2175]

                           rs361525 (TNF-238) A allele rs1800629 (TNF-308 G/A)     Positive assn w/PDR in T2DM (*P*=0.0001) No sig assn w/PDR in T2DM                                       Bengali Hindu (493 pts)                                                                                                                  Clinically assessed                                     [@b80-opth-9-2175]

                           rs1800629 (TNF-308 G/A)                                 No sig assn w/DR in T2DM                                                                                 Indian (Punjab; NW India -- 672 pts)                                                                                                     Clinically assessed                                     [@b57-opth-9-2175]

                           rs1800629 (TNF-308 G/A)                                 No sig assn w/DR in T2DM                                                                                 Brazilian (102 pts)                                                                                                                      Clinically assessed                                     [@b79-opth-9-2175]

                           rs1800629 (TNF-308 G/A)                                 No sig assn w/DR in T2DM                                                                                 Asian and European (meta-analysis of 5 studies -- 3041 pts)                                                                              Not reported                                            [@b113-opth-9-2175]

  *UCP1* and *UCP2*        rs1800592 (−3826A/G), G/G genotype in UCP1              Positive assn w/DR in T1DM (*P*=0.043)                                                                   Brazilian (257 pts)                                                                                                                      Clinically assessed                                     [@b115-opth-9-2175]

                           rs1800592 (−3826A/G), G/G genotype in UCP1              Positive assn w/PDR (*P*=0.03) but not NPDR in T2DM                                                      Chinese (792 pts)                                                                                                                        Clinically assessed                                     [@b97-opth-9-2175]

                           rs659366 866 G allele in promoter region in UCP2\       Positive assn w/PDR (*P*=0.016) but not NPDR in T2DM\                                                    Chinese (958 pts)                                                                                                                        Clinically assessed                                     [@b116-opth-9-2175]
                           rs660339 Ala55Val in exon 4 in UCP2                     No sig assn w/PDR/NPDR in T2DM                                                                                                                                                                                                                                                                            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** T2DM, type 2 diabetes mellitus; DR, diabetic retinopathy; NW, north west; CFH, complement factor H; CFB, complement factor B; PDR, proliferative diabetic retinopathy; CHN2, chimerin 2; NPDR, nonproliferative diabetic retinopathy; OR, odds ratio; CI, confidence interval; EPO, erythropoietin; GSTT1, glutathione S-transferase theta 1; GSTM1, glutathione S-transferase mu 1; ICAM-1, intercellular adhesion molecule-1; T1DM, type 1 diabetes mellitus; IFN-γ, interferon gamma; IL-6, interleukin-6; IL-10, interleukin-10; MCP-1, monocyte chemoattractant protein-1; PAI-1, plasminogen activator inhibitor-1; PPARγ, peroxisome proliferator-activated receptor gamma; TCF7L2, transcription factor 7-like-2; TGF-β1, transforming growth factor beta 1; TLR4, toll-like receptor 4; TNF-α, tumor necrosis factor alpha; MnSOD, manganese superoxide dismutase; UCP1, uncoupling protein 1; UCP2, uncoupling protein 2; assn, association; sig, significant; pts, participants; w/, with.

###### 

Candidate gene studies with no reported associations

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene     Polymorphism            Relation to diabetic retinopathy and significance level   Population and size (number of participants)                             Methodology (self-reported vs clinically assessed)      References
  -------- ----------------------- --------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------------------- ---------------------
  *HHEX*   rs7923837               No sig assn w/DR in T2DM                                  Chinese (1,129 pts)                                                      Not reported in abstract, original article in Chinese   [@b101-opth-9-2175]

           rs1111875               No sig assn w/DR in T1DM                                  Finnish (2,963 pts)                                                      Clinically assessed                                     [@b96-opth-9-2175]

  *SLC*    rs11558471\             No sig assn w/DR in T2DM\                                 Chinese (1,129 pts)                                                      Not reported in abstract, original article in Chinese   [@b101-opth-9-2175]
           rs13266634\             No sig assn w/DR in T2DM\                                                                                                                                                                  
           rs3802177               No sig assn w/DR in T2DM                                                                                                                                                                   

           rs13266634 in SLC30A8   No sig assn w/DR in T1DM                                  Finnish (2,963 pts)                                                      Clinically assessed                                     [@b96-opth-9-2175]

           SLC2A1 26177A/G         No sig assn w/DR in T2DM                                  Malaysian (211 pts)                                                      Clinically assessed                                     [@b119-opth-9-2175]

           rs13266634 in SLC30A8   No sig assn w/DR in T2DM                                  Chinese, Malaysian, and Asian Indians of Singapore (GWAS of 6,682 pts)   Clinically assessed                                     [@b120-opth-9-2175]
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** HHEX, hematopoietically expressed homeobox; DR, diabetic retinopathy; T2DM, type 2 diabetes mellitus; T1DM, type 1 diabetes mellitus; SLC, solute carrier; GWAS, genome-wide association study; assn, association; sig, significant; pts, participants.

###### 

Additional candidate gene studies and findings

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                                              Polymorphism                                                                        Relation to diabetic retinopathy and significance level                                                      Population and size (number of participants)                                                                                                                                                        Methodology (self-reported vs clinically assessed)   References
  ------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- ---------------------
  *CDKAL1*                                          rs10946398                                                                          No sig assn w/DR in T2DM                                                                                     Chinese (1,129 pts)                                                                                                                                                                                 Uncertain                                            [@b101-opth-9-2175]

  *CDKAL1*\                                         rs7754840\                                                                          No sig assn w/DR in T1DM                                                                                     Finnish (2,963 pts)                                                                                                                                                                                 Clinically assessed                                  [@b96-opth-9-2175]
  *CDKAL1*\                                         rs7756992\                                                                                                                                                                                                                                                                                                                                                                                                                                                
  CDKN2AB                                           rs10811661                                                                                                                                                                                                                                                                                                                                                                                                                                                

  *IGF2BP2*                                         rs1470579\                                                                          No sig assn w/DR in T1DM                                                                                     Finnish (2,963 pts)                                                                                                                                                                                 Clinically assessed                                  [@b96-opth-9-2175]
                                                    rs4402960                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  *HLA-DRB1*\                                       *DRB1*\*03:01 allele\                                                               Negative assn w/DR in T1DM (*P*=0.03)\                                                                       Caucasian (425 pts)                                                                                                                                                                                 Self-reported                                        [@b124-opth-9-2175]
  *HLA-DRB1*\                                       *DQA1*\*05:01DQB1\*02:01 haplotype\                                                 Negative assn w/DR in T1DM (*P*=0.031)\                                                                                                                                                                                                                                                                                                                               
  *HLA-B*                                           *DRB1*\*04:01 allele                                                                No sig assn w/DR in T1DM                                                                                                                                                                                                                                                                                                                                              

  *TMEM217*, *MRPL14*, and *GRIK2* (chromosome 6)   Multiple                                                                            Associations vary                                                                                            Chinese (749 pts)                                                                                                                                                                                   Clinically assessed                                  [@b125-opth-9-2175]

  *TBC1D4-COMMD6- UCHL3*\                           rs9565164\                                                                          Positive assn w/DR in T2DM (*P*=1.3×10^−7^)\                                                                 Chinese (1007 pts) but finding not replicated in Hispanic cohort (585 pts)                                                                                                                          Clinically assessed                                  [@b126-opth-9-2175]
  *LRP2-BBS5*\                                      rs1399634\                                                                          Positive assn w/DR in T2DM (*P*=2.0×10^−6^)\                                                                                                                                                                                                                                                                                                                          
  *ARL4C-SH3BP4*                                    rs2380261                                                                           Positive assn w/DR in T2DM (*P*=2.1×10^−6^)                                                                                                                                                                                                                                                                                                                           

  *PON*                                             rs662 (p.Q192R) in *PON1* rs854560 (p.L55M) in *PON1* rs7493 (p.S311C) in *PON2*\   No sig assn w/DR in DM Positive assn w/DR in DM (OR =2.42, 95% CI =1.91--3.07) No sig assn w/DR in DM\       Meta-analysis combining 2 Caucasian studies and 3 Asian studies (6,123 pts); patients were not stratified by type of diabetes in analyses                                                           Clinically assessed                                  [@b127-opth-9-2175]
                                                    rs12026 (p.A148G) in *PON2*                                                         No sig assn w/DR in DM                                                                                                                                                                                                                                                                                                                                                

  *OPG*                                             rs2073618 C allele in exon I\                                                       Positive assn w/DR in T2DM (*P*=0.004)\                                                                      Slovenian (645 pts)                                                                                                                                                                                 Clinically assessed                                  [@b128-opth-9-2175]
                                                    rs3134069 in promoter region                                                        No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                                              

  *RPSAP37* and *GRAMD3*\                           rs1073203\                                                                          Both "nominally associated" with DR in T1DM + T2DM or T2DM alone, but assn lost upon Bonferroni correction   Australian (463 pts)                                                                                                                                                                                Clinically assessed                                  [@b129-opth-9-2175]
  *ARHGAP22* (intron region)                        rs4838605                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  *KDR* (VEGFR), *AKR1B1*, and *PKC*-*β*            rs2071559 Multiple SNPs for different genes                                         No sig assn w/DR in T2DM                                                                                     Chinese (500 pts)                                                                                                                                                                                   Clinically assessed                                  [@b48-opth-9-2175]

  rs9362054                                         *RP1-90L14.1* (intron portion) adjacent to *KIAA1009/QN1/CEP162* gene               Borderline genome wide significance w/DR (*P*=1.4×10^−7^) but not PDR in T2DM                                Japanese (1,986 pts)                                                                                                                                                                                Clinically assessed                                  [@b130-opth-9-2175]

  *VDR*                                             rs2228570 (Fokl:C \> T)\                                                            Positive assn w/DR in T2DM (*P*\<0.01)\                                                                      Han Chinese (204 pts)                                                                                                                                                                               Clinically assessed                                  [@b131-opth-9-2175]
                                                    TT genotype\                                                                        No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                                                                             
                                                    rs1544410 (Bsml:G \> A)\                                                            No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                                              
                                                    rs7975232 (Apal:A \> C)                                                                                                                                                                                                                                                                                                                                                                                                                                   

  *SLMAP*                                           rs17058639 C allele\                                                                Positive assn w/DR in T2DM (*P*=0.009)\                                                                      Qatari (342 pts)                                                                                                                                                                                    Clinically assessed                                  [@b132-opth-9-2175]
                                                    rs1043045 C \> T\                                                                   No sig assn w/DR in T2DM\                                                                                                                                                                                                                                                                                                                                             
                                                    rs1057719 A \> G                                                                    No sig assn w/DR in T2DM                                                                                                                                                                                                                                                                                                                                              

  *Romo-1*                                          rs6060566                                                                           Positive assn w/DR in T2DM (*P*=0.024)                                                                       Caucasian (806 pts)                                                                                                                                                                                 Clinically assessed                                  [@b133-opth-9-2175]

  *FABP2*                                           Ala54Thr allele                                                                     Positive assn w/DR in T2DM (*P*=0.003)                                                                       Chinese (810 pts)                                                                                                                                                                                   Clinically assessed                                  [@b134-opth-9-2175]

  *RAAS* genes                                      *AGT* M235T\                                                                        No sig assn w/DR in both T1DM and T2DM in "bulk of assn studies" reviewed                                    Multiple (review of 73 studies)                                                                                                                                                                     Not reported                                         [@b135-opth-9-2175]
                                                    *ACE* I/D\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                    *AT1R*-A1166C                                                                                                                                                                                                                                                                                                                                                                                                                                             

  miR-126 genetic variant within *EGFL7*            rs4636297 A allele                                                                  Positive assn w/DR in T2DM (*P*=0.026)                                                                       Australian (531 pts)                                                                                                                                                                                Clinically assessed                                  [@b136-opth-9-2175]

  *KCNJ11*                                          rs5219 A allele                                                                     Positive assn w/DR in T2DM (*P*\<0.05)                                                                       Han Chinese (580 pts)                                                                                                                                                                               Clinically assessed                                  [@b137-opth-9-2175]

  *PLXDC2* (reported as "closest gene")             rs1571942\                                                                          No sig assn w/DR in T1DM\                                                                                    US studies, patient demographics not reported (1,907 pts)                                                                                                                                           Clinically assessed                                  [@b65-opth-9-2175]
                                                    rs12219125                                                                          No sig assn w/DR in T1DM                                                                                                                                                                                                                                                                                                                                              

  *ITGA2*\                                          BgI II (+ allele) (in LD w/807T/C poly so treated as one combined poly)\            Positive assn w/DR in T2DM (*P*=0.02)\                                                                       7 studies (3 Asian studies, 3 Caucasian studies, and 1 mixed study; 1,153 pts total) 4 studies (3 Caucasian studies and 1 Asian study; 1,908 pts total) (meta-analysis of 9 studies -- 3,007 pts)   Clinically assessed                                  [@b138-opth-9-2175]
  *ITGB3*                                           P1A1/A2 A2A2 genotype                                                               Negative assn w/DR in DM (3 studies = T2DM, 1 study = both T1DM and T2DM; *P*=0.002)                                                                                                                                                                                                                                                                                  

  *EL*                                              rs2000813 584C \> T TT genotype                                                     Positive assn w/"severe" NPDR in T2DM (OR =4.3, 95% CI =1.4--13.1)                                           French (287 pts)                                                                                                                                                                                    Clinically assessed                                  [@b139-opth-9-2175]

  *IGF-1*                                           −383 C/T\                                                                           No sig assn w/DR in T1DM\                                                                                    Caucasian (British -- 361 pts)                                                                                                                                                                      Clinically assessed                                  [@b106-opth-9-2175]
                                                    −1089 C/T                                                                           No sig assn w/DR in T1DM                                                                                                                                                                                                                                                                                                                                              

  p22phox (*CYBA*)\                                 rs4673 (p22phox 242C \> T)\                                                         No sig assn/DR in T2DM\                                                                                      South Indian (311 pts)                                                                                                                                                                              Clinically assessed                                  [@b36-opth-9-2175]
  *PARP-1*\                                         rs1136410 (762Ala allele)\                                                          Negative assn w/DR in T2DM (*P*=0.01)\                                                                                                                                                                                                                                                                                                                                
  *XRCC1*                                           rs25487 (399Gln allele)                                                             Positive assn w/DR in T2DM (*P*=0.02)                                                                                                                                                                                                                                                                                                                                 

  *HK1*\                                            rs16926246\                                                                         No sig assn w/DR in T2DM reported for all polymorphisms listed                                               Chinese, Malaysian, and Asian Indians of Singapore (GWAS of 6,682 pts)                                                                                                                              Clinically assessed                                  [@b120-opth-9-2175]
  *ANK1*\                                           rs7072268\                                                                                                                                                                                                                                                                                                                                                                                                                                                
  *MTNR1B*\                                         rs6474359\                                                                                                                                                                                                                                                                                                                                                                                                                                                
  *TMPRSS6*                                         rs4737009\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                    rs1387153\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                    rs855791                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Cytochrome P450                                   CYP2C19 poor metabolizer genotype                                                   Positive assn w/DR in T2DM in females only (OR =4.18, 95% CI =1.42--12.26)                                   Japanese (383 pts)                                                                                                                                                                                  Clinically assessed                                  [@b140-opth-9-2175]

  *CNR1*                                            rs1049353 (G1359A) A allele                                                         Positive assn w/DR in T2DM (*P*=0.0005)                                                                      Polish (1,117 pts)                                                                                                                                                                                  Clinically assessed                                  [@b141-opth-9-2175]

  Mitochondrial *ALDH2*                             *ALDH2*\*2 allele                                                                   Positive assn w/DR in T2DM (*P*=0.02)                                                                        Japanese (234 pts)                                                                                                                                                                                  Clinically assessed                                  [@b142-opth-9-2175]

  *MTHFR*                                           C677T TT genotype                                                                   Positive assn w/history of DR in DM (T1DM and T2DM combined) *P*=0.039                                       Turkish (230 pts)                                                                                                                                                                                   Clinically assessed                                  [@b143-opth-9-2175]

  *SDH*                                             rs3759890 (−888G \> C)                                                              No sig assn w/DR in T2DM                                                                                     Caucasian-Brazilian (446 pts)                                                                                                                                                                       Clinically assessed                                  [@b144-opth-9-2175]

  *ARMS2*                                           rs10490924                                                                          No sig assn w/DR in T1DM                                                                                     Spanish (147 pts)                                                                                                                                                                                   Clinically assessed                                  [@b62-opth-9-2175]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** PON, paraoxonase; OR, odds ratio; CI, confidence interval; OPG, osteoprotegerin; KDR, kinase insert domain receptor; VEGFR, vascular endothelial growth factor receptor; SNP, single nucleotide polymorphism; VDR, vitamin D receptor; SLMAP, sarcolemma associated protein; FABP2, fatty acid binding protein-2; Romo-1, reactive oxygen species modulator 1; FABP2, fatty acid binding protein-2; EL, endothelial lipase; IGF-1, insulin-like growth factor 1; GWAS, genome-wide association study; CNR1, cannabinoid type 1 receptor gene; ALDH2, aldehyde dehydrogenase 2; MTHFR, methylenetetrahydrofolate reductase; SDH, sorbitol dehydrogenase; DR, diabetic retinopathy; assn, association; sig, significant; w/, with; pts, participants; T2DM, type 2 diabetes mellitus; T1DM, type 1 diabetes mellitus; LD, linkage disequilibrium; PDR, proliferative diabetic retinopathy.
